Magnetoencephalography by Optical Pumping Magnetometer

NCT ID: NCT05835817

Last Updated: 2025-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-11

Study Completion Date

2026-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

MagnetoEncephaloGraphy (MEG) is a method of recording brain activity with high temporal resolution and good spatial resolution, compared to current recording techniques such as ElectroEncephaloGraphy (EEG). The main limitation of MEG is its cost due to the sensors used, the Super Quantum Interference Devices (SQUID). These require a complex infrastructure from an instrumentation point of view to operate, requiring liquid helium, most often at a loss, at increasing cost. Optical Pumping Magnetometers (OPM) type sensors represent a promising alternative to SQUIDs sensors, especially since they do not require helium cooling.

The purpose of this project is to Identify biomarkers in Magnetoencephalography of normal brain development in healthy adults, premature and term newborns from "a priori" obtained by the classical technique of High Resolution EEG performed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Magnetoencephalography Optical Pump Magnetometer Neonate Premature

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults

Group Type EXPERIMENTAL

Magnetoencephalography

Intervention Type OTHER

40 minutes of Magnetoencephalography with Optical Pump Magnetometer

full term neonates

Group Type EXPERIMENTAL

Magnetoencephalography

Intervention Type OTHER

40 minutes of Magnetoencephalography with Optical Pump Magnetometer

premature neonates

Group Type EXPERIMENTAL

Magnetoencephalography

Intervention Type OTHER

40 minutes of Magnetoencephalography with Optical Pump Magnetometer

pregnant women

Group Type EXPERIMENTAL

Magnetoencephalography

Intervention Type OTHER

40 minutes of Magnetoencephalography with Optical Pump Magnetometer

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetoencephalography

40 minutes of Magnetoencephalography with Optical Pump Magnetometer

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For healthy adult volunteers
* Age between 18 and 65
* No pathology, no treatment
* No toxicant intake
* For term newborns
* Child between 38 and 42 weeks gestational age on the day of registration
* No pathology, no treatment
* For children born prematurely
* Child between 28 and 36 weeks gestational age on the day of registration
* No pathology, no treatment apart from routine care related to prematurity
* For pregnant women
* Pregnant with between 28 to 40 weeks gestational age on the day of registration
* No pathology, no treatment

Exclusion Criteria

* Subject and Patients "not compatible" MEG. Wearers of prosthesis or pacemaker likely to generate artefacts interfering with the measurement. There is no danger to the subject, but the measurement itself may be impossible.
* Patients who cannot stand to stand still for a few minutes.
* Newborn on ventilatory assistance or infusion
* Newborn baby not meeting the age criteria
Minimum Eligible Age

1 Day

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire, Amiens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Amiens

Amiens, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fabrice Wallois, Pr

Role: CONTACT

03 22 08 80 51

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Fabrice Wallois, Pr

Role: primary

(33)322087775

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI2021_843_0205

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.